Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] - N0000175821

Pharmacologic Class Information

Pharmacologic Code N0000175821
Pharmacologic Name Hydrolytic Lysosomal Glycogen-specific Enzyme
Pharmacologic Uses
  • hydrolytic lysosomal glycogen-specific enzyme
Pharmacologic Concept Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions:
  • A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication.
  • A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

NDC Products with Hydrolytic Lysosomal Glycogen-specific Enzyme

The following table contains 1 products whose active ingredient are classified under the same pharmacologic class Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
58468-0160Lumizyme Non-Proprietary Name: Alglucosidase AlfaInjection, Powder, For SolutionIntravenousGenzyme CorporationACTIVE